Evaluation of c-ras oncogene product (p21) in superficial bladder cancer.

@article{Fontana1996EvaluationOC,
  title={Evaluation of c-ras oncogene product (p21) in superficial bladder cancer.},
  author={Dario Fontana and Maurizio Bellina and Cesare Marco Scoffone and Eugenio Cagnazzi and Susanna Cappia and Federica Cavallo and Roberto Russo and E. J. Leonardo},
  journal={European urology},
  year={1996},
  volume={29 4},
  pages={470-6}
}
OBJECTIVES The aim of our study is the evaluation of the prognostic importance of p21 protein in superficial bladder cancer. METHODS One hundred and fourteen patients with an initial diagnosis of monofocal bladder cancer (stage Ta-T1) following TUR were investigated. On the tissue removed by TUR, besides the usual pathological evaluation, an immuno-histochemical investigation was carried out in order to ascertain the presence of c-ras oncogene product (protein p21). The actuarial curves… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Molecular pathogenesis of urothelial bladder cancer.

Histology and histopathology • 2003
View 5 Excerpts
Highly Influenced

Reduced lecithin: retinol acyltransferase expression correlates with increased pathologic tumor stage in bladder cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2004

Similar Papers

Loading similar papers…